(Q33363081)
Statements
1 reference
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma (English)
1 reference
Jagannath S
1 reference
Barlogie B
1 reference
Berenson J
1 reference
Siegel D
1 reference
Irwin D
1 reference
Richardson PG
1 reference
Niesvizky R
1 reference
Alexanian R
1 reference
Limentani SA
1 reference
Alsina M
1 reference
Adams J
1 reference
Kauffman M
1 reference
Esseltine DL
1 reference
Schenkein DP
1 reference
Anderson KC
1 reference
1 October 2004
1 reference
1 reference
Identifiers
1 reference